title: Plasma homocysteine level and uveitis in Behçet's disease.
abstract: BACKGROUND
  Behçet's disease is a chronic relapsing systemic vasculitis of unknown origin in which orogenital ulceration, skin lesions and uveitis are prominent features. Patients with BD have been recognized to be at greater risk for vascular diseases such as thrombosis and aneurysms. Uveitis in BD is usually accompanied by retinal vaso-occlusive disease.
  
  
  OBJECTIVE
  To investigate the possible role of hyperhomocysteinemia as a prethrombotic disorder in the development of uveitis.
  
  
  METHODS
  The study population consisted of 29 patients with BD (13 males and 16 females with a mean age of 32.3 years, range 21-52) and 24 healthy controls. All patients fulfilled the criteria of the International Study Group for BD. The patients were categorized as having active (n = 8) or inactive disease (n = 11) or only uveitis (n = 10). Plasma fasting homocysteine and C-reactive protein levels were studied in all patients and controls. The fasting homocysteine level was significantly higher in patients with only uveitis than in inactive patients and controls (P = 0.029 and P = 0.26 respectively). It was also higher in patients with active disease compared to healthy controls (P = 0.,001). However, no significant difference was found between homocysteine levels of patients with active or inactive disease (P = 0.69). CRP, as a marker of disease activity, was higher in active BD and in patients with only uveitis than in controls (P = 0.01 and P = 0.001 respectively).
  
  
  CONCLUSIONS
  Homocysteine may play a role in ocular involvement of BD. Chronic inflammation can induce hyperhomocysteinemia, thereby leading to thrombosis in the retinal vascular bed in a way similar to that recently proposed for the pathogenesis of coronary artery disease.
authors.affiliation: Department of Ophthalmology, Faculty of Medicine, University of Seluk, Konya, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Okka
authors.forename: Mustafa
authors.initials: M
authors.lastname: Oztürk
authors.forename: M Cem
authors.initials: MC
authors.lastname: Kockar
authors.forename: Nüket
authors.initials: N
authors.lastname: Bavbek
authors.forename: Yaacov
authors.initials: Y
authors.lastname: Rasier
authors.forename: Kemal
authors.initials: K
authors.lastname: Gunduz
authors.forename: M Cem
authors.initials: MC
authors.lastname: Korkar
mesh_terms: D000293:Adolescent; D000328:Adult; D001528:Behcet Syndrome / Q000145:classification / Q000209:etiology* / Q000276:immunology; D002097:C-Reactive Protein / Q000378:metabolism; D016022:Case-Control Studies; D005215:Fasting; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood* / Q000150:complications* / Q000276:immunology; D007249:Inflammation; D008297:Male; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000209:etiology* / Q000276:immunology; D012175:Retinoblastoma; D012307:Risk Factors
chemical_list: D006710:Homocysteine; D002097:C-Reactive Protein